[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@LSciStartupNews Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1492531068783800325.png) @LSciStartupNews LifeSci Startup

LifeSci Startup posts on X about sanofi, $sny, $101m, lux the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1492531068783800325/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1492531068783800325/c:line/m:interactions.svg)

- X Week XXXXX +191%
- X Month XXXXX +47%
- X Months XXXXX +1,229%
- X Year XXXXX +226%

### Mentions: X [#](/creator/twitter::1492531068783800325/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1492531068783800325/c:line/m:posts_active.svg)

- X Week X +60%
- X Month XX +9.50%
- X Months XX +315%
- X Year XX +128%

### Followers: XXX [#](/creator/twitter::1492531068783800325/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1492531068783800325/c:line/m:followers.svg)

- X Week XXX +0.76%
- X Month XXX +1.50%
- X Months XXX +5.60%
- X Year XXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::1492531068783800325/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1492531068783800325/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1492531068783800325/influence)
---

**Social category influence**
[finance](/list/finance)  XXXXX% [stocks](/list/stocks)  XXXXX% [vc firms](/list/vc-firms)  #608 [technology brands](/list/technology-brands)  XXXX%

**Social topic influence**
[sanofi](/topic/sanofi) 18.18%, [$sny](/topic/$sny) 18.18%, [$101m](/topic/$101m) 9.09%, [lux](/topic/lux) 9.09%, [lux capital](/topic/lux-capital) 9.09%, [neural](/topic/neural) 9.09%, [$11m](/topic/$11m) 9.09%, [polaris partners](/topic/polaris-partners) 9.09%, [$120m](/topic/$120m) 9.09%, [newsletter](/topic/newsletter) XXXX%

**Top assets mentioned**
[Sanofi (SNY)](/topic/sanofi) [Synthetify (SNY)](/topic/$sny)
### Top Social Posts [#](/creator/twitter::1492531068783800325/posts)
---
Top posts by engagements in the last XX hours

"Nilo Therapeutics has launched from stealth with a $101M Series A led by The Column Group DCVC Bio & Lux Capital with support from the Gates Foundation & Alexandria Venture Investments. The biotech aims to restore immune balance via neural circuits. 🔗"  
[X Link](https://x.com/LSciStartupNews/status/1976024886566060228) [@LSciStartupNews](/creator/x/LSciStartupNews) 2025-10-08T20:40Z XXX followers, XXX engagements


"Cirrus Therapeutics has raised $11M in seed financing led by ClavystBio with Polaris Partners and SEEDS. The funding will advance its lead AAV gene therapy targeting loss of IRAK-M protein a key driver of dry AMD to reverse disease progression. 🔗"  
[X Link](https://x.com/LSciStartupNews/status/1974180148984562079) [@LSciStartupNews](/creator/x/LSciStartupNews) 2025-10-03T18:30Z XXX followers, XX engagements


"Pelage Pharmaceuticals has raised $120M Series B to advance PP405 a topical therapy designed to reactivate dormant hair follicle stem cells and restore natural hair growth. PP405 represents a new frontier in regenerative medicine"  
[X Link](https://x.com/LSciStartupNews/status/1978586677141479466) [@LSciStartupNews](/creator/x/LSciStartupNews) 2025-10-15T22:19Z XXX followers, 1282 engagements


"Top LifeSci Startup news featured in our October 16th newsletter: Veradermics' Oversubscribed $150M Series C; EVOQ Therapeutics Sanofi's $SNY License Deal; Liberate Bio Emerges #healthcare #biotech #lifescience #HealthTech #AI"  
[X Link](https://x.com/LSciStartupNews/status/1978872234501640268) [@LSciStartupNews](/creator/x/LSciStartupNews) 2025-10-16T17:14Z XXX followers, XX engagements


"$SNY expands its autoimmune portfolio through a $500M partnership with EVOQ Therapeutics leveraging its NanoDisc platform to restore immune tolerance and advance new treatments for celiac disease and type X diabetes. #healthcare #lifescience"  
[X Link](https://x.com/LSciStartupNews/status/1978922074719522856) [@LSciStartupNews](/creator/x/LSciStartupNews) 2025-10-16T20:32Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@LSciStartupNews LifeSci Startup

LifeSci Startup posts on X about sanofi, $sny, $101m, lux the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

X Week XXXXX +191%
X Month XXXXX +47%
X Months XXXXX +1,229%
X Year XXXXX +226%

Mentions: X #

X Week X +60%
X Month XX +9.50%
X Months XX +315%
X Year XX +128%

Followers: XXX #

X Week XXX +0.76%
X Month XXX +1.50%
X Months XXX +5.60%
X Year XXX -XXXX%

CreatorRank: undefined #

Social Influence #

Social category influence finance XXXXX% stocks XXXXX% vc firms #608 technology brands XXXX%

Social topic influence sanofi 18.18%, $sny 18.18%, $101m 9.09%, lux 9.09%, lux capital 9.09%, neural 9.09%, $11m 9.09%, polaris partners 9.09%, $120m 9.09%, newsletter XXXX%